Case Study: The Ackman vs. Herbalife Saga - Lessons for Traders
The Black Book of Day Trading Strategies
1,000 complete strategies · 31 chapters · Full trade plans
Disclaimer: This article is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any security.
Case Study: The Ackman vs. Herbalife Saga - Lessons for Traders
The battle between hedge fund titan Bill Ackman and nutritional supplement company Herbalife is one of the most epic and public activist campaigns in financial history. It was a zero-sum game, a battle of titans that pitted Ackman's massive short position against a coalition of long investors, including his arch-nemesis, Carl Icahn. The saga offers a wealth of lessons for traders on the nature of activist short-selling, the importance of narrative in shaping market perception, and the risks of taking on a effective and determined opponent.
The Short Thesis: A Pyramid Scheme Accusation
In December 2012, Bill Ackman, through his fund Pershing Square Capital Management, publicly declared that he had taken a $1 billion short position in Herbalife. His thesis was simple and devastating: Herbalife was a pyramid scheme. Ackman alleged that the company's business model was based not on selling products to real customers, but on recruiting a constantly churning base of distributors who were the primary consumers of the products. He claimed that the vast majority of these distributors lost money and that the company was in violation of federal law.
The Campaign: A Public Relations Blitz
Ackman's campaign was as much a public relations war as it was a financial one. He gave a series of multi-hour, highly detailed presentations, complete with a 342-slide deck, laying out his case against the company. He lobbied regulators, including the Federal Trade Commission (FTC), to investigate Herbalife. He even launched a website, "HerbalifePyramidScheme.com," to disseminate his research.
The Counter-Attack: The Longs Strike Back
Herbalife did not take Ackman's attack lying down. The company mounted a vigorous defense, refuting his claims and accusing him of market manipulation. More importantly, a number of prominent investors, including Carl Icahn and George Soros, took the other side of Ackman's trade, buying up large stakes in Herbalife. Icahn, in a now-famous on-air phone call with Ackman on CNBC, called him a "liar" and a "crybaby."
| Investor | Position | Stated Rationale |
|---|---|---|
| Bill Ackman (Pershing Square) | Short | Herbalife is a pyramid scheme |
| Carl Icahn (Icahn Enterprises) | Long | Herbalife is a legitimate business and Ackman is wrong |
| George Soros (Soros Fund Management) | Long | The stock is undervalued |
| Daniel Loeb (Third Point) | Long | Ackman's thesis is flawed |
The Climax: The FTC Settlement
The turning point in the saga came in July 2016, when the FTC announced a settlement with Herbalife. The company agreed to pay a $200 million fine and to restructure its business to focus more on retail sales. However, the FTC stopped short of calling Herbalife a pyramid scheme. This was a blow to Ackman's thesis, as it allowed the company to continue operating.
The Aftermath: A Costly Defeat
In February 2018, after five years and hundreds of millions of dollars in losses, Ackman finally capitulated, closing out his short position. The stock had more than doubled since he had initiated his bet against it.
Lessons for Traders
The Ackman vs. Herbalife saga offers several key lessons for traders:
- The Power of Narrative: This was a battle of competing narratives. Ackman's "pyramid scheme" narrative was effective, but it was ultimately overcome by the "legitimate business" narrative championed by the longs.
- The Risk of a Crowded Short: When a short position becomes too well-known and crowded, it can be vulnerable to a short squeeze. The presence of effective investors on the long side made it impossible for Ackman to win.
- The Importance of a Definitive Catalyst: Ackman's thesis was predicated on a regulatory shutdown of the company. When that didn't happen, his thesis fell apart.
- The Danger of Confirmation Bias: Ackman became so convinced of his own thesis that he was unable to objectively assess the evidence that contradicted it.
Conclusion
The Ackman vs. Herbalife saga is a cautionary tale about the dangers of hubris and the complexities of activist short-selling. It is a reminder that even the most well-researched and passionately argued thesis can be wrong. For traders, the key takeaway is the importance of humility, objectivity, and a healthy respect for the power of the market to prove even the most confident investors wrong.
References
[1] Copeland, R. (2018, March 1). Bill Ackman, After Big Loss, Exits Bet Against Herbalife. The Wall Street Journal.
[2] FTC. (2016, July 15). Herbalife Will Restructure Its Multi-Level Marketing Operations and Pay $200 Million For Consumer Redress to Settle FTC Charges. Federal Trade Commission.
[3] Hasen, R. L. (2015). Activist short-selling. Loyola of Los Angeles Law Review, 49, 837.